HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 20, No 12, December 2016 – Medical Imaging Technology       » Climate Change Could Hurt Coffee, Help Banana Production       » Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific       » Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease       » NUS Scientists Discover the "Switch" that Makes Breast Cancer Cells Aggressive      
EYE ON CHINA
UroFlex now CE-marked; Chinese SFDA approval for Cellvizio
Mauna Kea Technology's UroFlex confocal miniprobe has received CE mark approval for use during cystoscopy procedures. UroFlex is believed to be the first optical biopsy probe designed for urological applications and allows the company to enter the EUR 1 billion European urology device market. The new probe allows physicians to obtain optical biopsies that may facilitate the diagnosis, surveillance and treatment of patients with bladder cancer. The CE mark extends Mauna Kea's Cellvizio portfolio beyond the gastrointestinal tract and lungs into the field of urology.

Clinical studies have demonstrated that optical biopsies with Cellvizio could help urologists determine if they have removed all cancerous cells during transurethral resection of the bladder tumour, the initial surgical procedure that a patient undergoes after the diagnosis of bladder cancer. Data also showed that optical biopsies can help physicians characterize lesions during long-term surveillance of bladder cancer patients.

In addition, Mauna Kea's Cellvizio has received SFDA approval in China, one of the fastest growing, largest medical device markets in the world. Concurrently, Mauna Kea has entered into a strategic partnership with Fujifilm Investment Co, a subsidiary of Fujifilm Holdings. The partners will work together to develop the Cellvizio market throughout China in various indications, such as gasteroenterology and pulmonology.

Fujifilm benefits from growth in its endoscopy market in China, and has established a strong distribution network all over the country. There are 800 advanced endoscopy centres in tertiary referral hospitals in China, which will constitute the primary target for Cellvizio.

Cellvizio is a probe-based confocal laser endomicroscopy system that provides high-resolution cellular views of tissue inside the body. Cellvizio has 510(k) clearance from the FDA and the European CE mark for use in the gastrointestinal tract, biliary and pancreatic ducts and lungs.

Click here for the complete issue.

NEWS CRUNCH  
news Accuron Technologies' MedTech Division Invests into AWAK Technologies
news Philips introduces PerformanceBridge suite of operational performance improvement software and services for radiology departments
news Give a Gift that Will Last a Lifetime this Holiday Season with Smile Train
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Lungs & Respiratory System
February:
Cancer Research, Treatment/Technology
March:
Traditional Chinese Medicines
April:
Eye Care/ Eye Health
May:
The Piece of Your Mind - Brain Health/Science
June:
Featuring Biotech Start-Ups/Companies
July:
Food Science & Technology
August:
Diabetics Technology
September:
No. 1 Killer - Heart Diseases, Diagnosis and Treatment
October:
Skin Diseases/Allergic Reactions
November:
Diseases threatening our Children
December:
Liver Health & Treatment/Technology
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy